JPRN-UMIN000037043已完成未知
Variable effects of diabetes-related medications on SGLT2-induced eGFR changes in diabetic patients - SGLT2-induced eGFR changes in diabetic patients
Tokyo Bay Urayasu Ichikawa Medical Center0 个研究点目标入组 255 人开始时间: 2019年6月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 255
研究概览
简要总结
Background treatment with metformin diminished the SGLT2i induced reductions in eGFR after 3 months of SGLT2i therapy in patients with type 2 diabetes and hypertension(-2.29?? vs -5.85????L/min/1.73m2?? for metformin users (n=126) and nonusers (n=97), respectively).
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who fall under any of HbA1c> 11.0, use of steroids, use of immunosuppressant, use of NSAID, or other acute disease
研究者
相似试验
已完成
不适用
Effect of Metformin on the esRAGE levels in type 2 diabetic patients: the Metformin Sitagliptin Randomized TrialType 2 DiabetesJPRN-UMIN000005253Osaka City University Graduate School of Medicine, Metabolism, Endocrinology, and Molecular Medicine60
尚未招募
2 期
The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection FractionHeart Failure With Preserved Ejection FractionDiabete Type 2NCT06080802October University for Modern Sciences and Arts80
已完成
不适用
Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes SplicingType 2 DiabetesNCT01349387Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète25
尚未招募
2 期
Metformin in overweight adults with type 1 diabetes mellitusOverweight/obesityMetabolic and Endocrine - DiabetesDiet and Nutrition - ObesityType 1 diabetes mellitusACTRN12612000660886Professor Peter Clifton100
已完成
不适用
The effect of metformin on blood glucose control in patients with type I diabetesutritional, Metabolic, Endocrine: DiabetesNutritional, Metabolic, EndocrineDiabetesISRCTN55324082Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)20